Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
ABSTRACT Severe fever with thrombocytopenia syndrome virus (SFTSV) is the causative agent of SFTS, an emerging hemorrhagic fever. This disease has a high case fatality rate and is endemic to China, South Korea, and Japan. Because there are currently no effective therapeutics for SFTS, potent and saf...
Guardado en:
Autores principales: | Hideki Tani, Aiko Fukuma, Shuetsu Fukushi, Satoshi Taniguchi, Tomoki Yoshikawa, Naoko Iwata-Yoshikawa, Yuko Sato, Tadaki Suzuki, Noriyo Nagata, Hideki Hasegawa, Yasuhiro Kawai, Akihiko Uda, Shigeru Morikawa, Masayuki Shimojima, Haruo Watanabe, Masayuki Saijo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a907b03c91a445f0be2fcc816c35eb99 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Favipiravir Inhibits Mayaro Virus Infection in Mice
por: Michèle Bengue, et al.
Publicado: (2021) -
Evaluation of favipiravir treatment before intensive care in COVID-19 patients
por: Osman Ozudogru, et al.
Publicado: (2021) -
Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
por: Qomara WF, et al.
Publicado: (2021) -
Favipiravir treatment prolongs the survival in a lethal mouse model intracerebrally inoculated with Jamestown Canyon virus.
por: Hirofumi Kato, et al.
Publicado: (2021) -
Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review
por: Kritika Srinivasan, et al.
Publicado: (2021)